Abstract:Triptorelin has been used after surgery in deep infiltrating endometriosis. This post-hoc analysis aimed to evaluate symptom control between patients receiving 1-3 triptorelin injections and those receiving 4-6 injections within 24 months of conservative surgery for deep infiltrating endometriosis, in the real-world. Included patients were divided into two groups (received up to 3 months injections in group A, 4-6 injections in group B) based on the numbers of triptorelin (Diphereline, 3.75 mg intramuscular injection once every 28 days for up to 24 weeks) administration. Evolution in score of pain intensity at 3, 6, 9, 12, 18, and 24 months after primary triptorelin administration and symptom improvement/recurrence rates between two groups were compared. Symptoms of pain intensity were assessed using a visual analogue scale (VAS) with a range from 0 to 10 cm. An improvement in symptoms was defined as a reduction of at least 3 cm or 3 units from pre-surgery levels. 156 patients in group A and 228 in group B. Pain symptom score (mean +/- standard deviation) diminished to a nadir at 3-months for group A and 6-months for group B; at 6-months nadir scores were significantly lower in group B (0.9 +/- 1.7 vs 0.4 +/- 1.2 respectively, P = .002). No significant difference for pain symptom scores between both groups at 24-months (P = .269). The 6-month and 24-month cumulative improvement rates of pain (80.6% vs 89.8%, P = .014 and 82.6% vs 90.7%, P = .025) and gastro-intestinal symptoms (61.0% vs 80.8%, P = .022 and 61.0% vs 83.3%, P = .008) were significantly higher in group B, whereas there was no significant difference in rates of menstrual disorders and urinary symptoms. There is no significant difference for 12-months and 24-months cumulative recurrence rates of total symptoms between both groups (11.3% vs 13.8%, P = .568 and 16.1% vs 26.0%, P = .094). In women with deep infiltrating endometriosis, longer treatment with triptorelin following conservative surgery was associated with a decrease in symptom intensity and greater improvement of pain symptoms in the short-term and greater improvement of gastro-intestinal symptoms in the long-term. Trial registration number: ClinicalTrials.gov, NCT01942369.

Comparison of the curative effects of triptorelin before and after laparoscopic surgery in treatment of stage Ⅳ endometriosis

Symptom control after different duration of triptorelin treatment following conservative surgery for deep infiltrating endometriosis Post-hoc analysis of a multicentre, prospective, real-world study

The Efficacy and Safety of Triptorelin-Therapy Following Conservative Surgery for Deep Infiltrating Endometriosis A Multicenter, Prospective, Non-Interventional Study in China

The efficacy and safety of up to 24 weeks of triptorelin therapy following conservative surgery in patients with deep infiltrating endometriosis (DIE): a multicentre, prospective, non-interventional study in China

Effect of gonadotropin-releasing hormone agonist therapy after laparoscopic conservative surgery with moderate to severe endometriosis

[Comparison of Surgery for Staging Using Laparoscopy and Laparotomy in Patients with Endometrial Cancer].

Effects comparison between the uterine arterial occlusion and preoperative application of small dosage of Triptorelin in laparoscopic resection of adenomyosis

The value of preoperative GnRH analogue treatment for stage IV endometriosis with laparoscopic conservative surgery

A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women

Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.

The clinical curative effect and the conception situation of conservative operation combined with goserelin treatment on endometriosis

Clinical Significance of Triptorelin Application before Laparoscopic Resection of Large Uterine Fibroids in 153 Cases

Curative Effect of 1.88-Mg and 3.75-Mg Gonadotrophin-Releasing Hormone Agonist on Stage III-IV Endometriosis: Randomized Controlled Study.

Meta-analysis on Therapeutic Effect Between Single Laparoscopic Surgery and Postoperative Therapy by GnRHa in Endometriosis

Comparative Analysis Between Laparoscopic Operation and Laparotomy in Treating Early Stage of Cervical and Endometrial Carcinomas

Comparative Study on the Efficacy of Yiweining (异位宁) and Gestrinone for Post-operational Treatment of Stage Ⅲ Endometriosis

Comparison of hysterectomy via three routes treating endometriosis

Therapeutic Effects of GnRH-a Combined with Laparoscopy on Endometriosis and Its Effects on Levels of VEGF,IL-18 ;and TNF-α

Comparison of Laparoscopic and Open Surgeries for Early-stage Endometrial Carcinoma

Comparison of effects of Leuprorelin and Marvelon in on endometriosis after laparoscopic surgery

Operation modes and postoperative treatment of endometriosis of the ovary